Delphi advisor to Paxman in public acquisition of Dignitana

Delphi has assisted Paxman AB (publ) in connection with Paxman’s public acquisition of Dignitana AB (publ), which has now been decided to be completed. Through the acquisition, shares issued by Dignitana are transferred to Paxman in exchange for approximately 0.0307 newly issued shares in Paxman per share in Dignitana.

The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. With close to 6,000 systems delivered to hospitals, clinics and treatment centers around the world, Paxman is the leading supplier of Scalp Cooling technology. Paxman has its headquarters in Karlshamn (Sweden), with subsidiaries in Huddersfield (UK), Houston, Texas (US) and Toronto, Ontario (CA).

Delphi’s team consisted of Anders Jemail, Ludvig Borg, and Elfie Ekegren Franzetti.